J1 J1 (Cephalexin monohydrate 250 mg)
Pill imprint J1 J1 has been identified as Cephalexin monohydrate 250 mg.
Cephalexin is used in the treatment of bacterial infection; skin infection; bladder infection; upper respiratory tract infection; bacterial endocarditis prevention (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for J1 J1
- 250 mg
- Green & White
- 18.00 mm
- Prescription only
- Drug Class:
- First generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
D&C Yellow No. 10
FD&C Blue No. 2
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|54569-0304||A S Medication Solutions LLC (repackager)|
|43063-0016||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about cephalexin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.